Literature DB >> 7946045

Mucosal immunity to infection with implications for vaccine development.

H F Staats1, R J Jackson, M Marinaro, I Takahashi, H Kiyono, J R McGhee.   

Abstract

The induction of effective mucosal immunity that also provides systemic immunity is a considerable challenge. Over the past two years, efforts to develop novel mucosal vaccine delivery systems to induce mucosal immunity against bacterial and viral diseases, including HIV, have dramatically increased. Here we cite novel vaccines and delivery systems being used to establish effective mucosal immunity.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946045     DOI： 10.1016/0952-7915(94)90144-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  51 in total

Review 1.  The immunobiology of Acanthamoeba keratitis.

Authors:  J Y Niederkorn; H Alizadeh; H F Leher; J P McCulley
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

Authors:  William M Gwinn; Shaun M Kirwan; Sheena H Wang; Kathleen A Ashcraft; Neil L Sparks; Catherine R Doil; Tom G Tlusty; Leslie S Casey; Susan K Hollingshead; David E Briles; Richard S Dondero; Anthony J Hickey; W Michael Foster; Herman F Staats
Journal:  Vaccine       Date:  2010-08-17       Impact factor: 3.641

4.  Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.

Authors:  Dora Li; Jennifer O'Leary; Yan Huang; Norman P A Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2005-12-02       Impact factor: 4.570

6.  Transgenic mice secreting coronavirus neutralizing antibodies into the milk.

Authors:  I Sola; J Castilla; B Pintado; J M Sánchez-Morgado; C B Whitelaw; A J Clark; L Enjuanes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.

Authors:  G H Lowell; C Colleton; D Frost; R W Kaminski; M Hughes; J Hatch; C Hooper; J Estep; L Pitt; M Topper; R E Hunt; W Baker; W B Baze
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

8.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Authors:  T Muster; B Ferko; A Klima; M Purtscher; A Trkola; P Schulz; A Grassauer; O G Engelhardt; A García-Sástre; P Palese
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.